Logo image of CYBE.CA

CYBERCATCH HOLDINGS INC (CYBE.CA) Stock Fundamental Analysis

TSX-V:CYBE - TSX Venture Exchange - CA23250C2013 - Common Stock - Currency: CAD

0.56  0 (0%)

Fundamental Rating

0

Overall CYBE gets a fundamental rating of 0 out of 10. We evaluated CYBE against 0 industry peers in the Unkown industry. CYBE has a bad profitability rating. Also its financial health evaluation is rather negative. CYBE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CYBE had negative earnings in the past year.
CYBE had a negative operating cash flow in the past year.
CYBE.CA Yearly Net Income VS EBIT VS OCF VS FCFCYBE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Industry RankSector Rank
ROA -861.48%
ROE N/A
ROIC N/A
ROA(3y)-785.51%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYBE.CA Yearly ROA, ROE, ROICCYBE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

CYBE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYBE.CA Yearly Profit, Operating, Gross MarginsCYBE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

0

2. Health

2.1 Basic Checks

CYBE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYBE has about the same amout of shares outstanding than it did 1 year ago.
CYBE has a worse debt/assets ratio than last year.
CYBE.CA Yearly Shares OutstandingCYBE.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
CYBE.CA Yearly Total Debt VS Total AssetsCYBE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -85.29, we must say that CYBE is in the distress zone and has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -85.29
ROIC/WACCN/A
WACC9.6%
CYBE.CA Yearly LT Debt VS Equity VS FCFCYBE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M -4M -6M -8M -10M

2.3 Liquidity

CYBE has a Current Ratio of 0.06. This is a bad value and indicates that CYBE is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.06 indicates that CYBE may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
CYBE.CA Yearly Current Assets VS Current LiabilitesCYBE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

CYBE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.47%, which is quite impressive.
The Revenue has grown by 144.72% in the past year. This is a very strong growth!
EPS 1Y (TTM)79.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.13%
Revenue 1Y (TTM)144.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-22.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYBE.CA Yearly Revenue VS EstimatesCYBE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 200K 400K 600K 800K 1M
CYBE.CA Yearly EPS VS EstimatesCYBE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CYBE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYBE.CA Price Earnings VS Forward Price EarningsCYBE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYBE.CA Per share dataCYBE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CYBE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYBERCATCH HOLDINGS INC

TSX-V:CYBE (3/7/2025, 7:00:00 PM)

0.56

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners37.48%
Ins Owner ChangeN/A
Market Cap10.00M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.89
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.04
BVpS-0.18
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -861.48%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.14%
FCFM N/A
ROA(3y)-785.51%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -85.29
F-Score5
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)144.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-22.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.11%
OCF growth 3YN/A
OCF growth 5YN/A